To assess whether this synergistic anti-tumor effect is mediated through CD8+ T cell population, tumor-bearing mice were treated with VC and anti-PD-L1 antibody in the presence of either IgG Ctrl or anti-CD8 antibody to deplete CD8+ T cells (Supplementary Fig. 15b). Here, CD8A is linked to neoplasm.